ACM
STIM icon

ADAR1 Capital Management’s Neuronetics STIM Stock Holding History

ADAR1 Capital Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Hold
100,000
– – 0.01% 258
2026
Q1 		$145K Buy
+100,000
New +$159K 0.01% 274

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ADAR1 Capital Management's STIM Position: Q2 2026 in Review

ADAR1 Capital Management held its Neuronetics (STIM) position steady in Q2 2026 at 100,000 shares worth $130K. The position accounts for 0.01% of the portfolio, ranked #258.

ADAR1 Capital Management first reported a position in STIM in Q1 2026 and has held it in 2 quarters since. The position peaked at $145K in Q1 2026. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • ADAR1 Capital Management held 100,000 shares of Neuronetics worth $130K as of Q2 2026.
  • ADAR1 Capital Management left its Neuronetics share count unchanged in Q2 2026.
  • Neuronetics made up 0.01% of ADAR1 Capital Management's portfolio in Q2 2026, its #258 holding.
  • ADAR1 Capital Management first reported a position in Neuronetics in Q1 2026 and has held it in 2 quarters since.
  • ADAR1 Capital Management's Neuronetics position peaked at $145K in Q1 2026.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.